CenterBook Partners LP Purchases 2,846 Shares of UnitedHealth Group Incorporated $UNH

CenterBook Partners LP purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the third quarter, HoldingsChannel.com reports. The firm purchased 2,846 shares of the healthcare conglomerate’s stock, valued at approximately $1,045,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. Corient Private Wealth LP purchased a new stake in shares of UnitedHealth Group in the second quarter valued at about $245,516,000. Legal & General Group Plc purchased a new position in UnitedHealth Group during the second quarter worth about $2,444,928,000. Jupiter Topco LLC acquired a new stake in UnitedHealth Group in the second quarter valued at about $2,019,844,000. BlackRock Inc. boosted its holdings in UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after purchasing an additional 3,395,530 shares in the last quarter. Finally, Canada Pension Plan Investment Board purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $971,757,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

UNH opened at $404.88 on Wednesday. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The stock has a market cap of $362.78 billion, a P/E ratio of 23.12, a P/E/G ratio of 1.44 and a beta of 0.51. The stock’s 50 day simple moving average is $390.98 and its 200 day simple moving average is $364.53. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.72 billion during the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. UnitedHealth Group’s revenue was down .4% on a year-over-year basis. During the same period in the previous year, the firm posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Monday, December 7th. UnitedHealth Group’s payout ratio is 53.00%.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.19% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $370.00 to $467.00 and gave the company a “hold” rating in a report on Friday, July 17th. Weiss Ratings upgraded UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. The Goldman Sachs Group boosted their target price on shares of UnitedHealth Group from $435.00 to $490.00 and gave the stock a “buy” rating in a research report on Friday, July 17th. Jefferies Financial Group upped their price target on shares of UnitedHealth Group from $401.00 to $490.00 and gave the stock a “buy” rating in a research note on Friday, July 17th. Finally, Cantor Fitzgerald increased their price target on shares of UnitedHealth Group from $440.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 17th. Twenty research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $463.93.

View Our Latest Report on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.